Frontlight ResearchEarly access
Trial site
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Gastric and oesophageal cancer2 trials
- Bladder cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Cullinan Therapeutics Inc.1 trial
- Genentech, Inc.1 trial
- Jazz Pharmaceuticals1 trial
- Nagoya City University1 trial
- Nuvalent Inc.1 trial
Running trials
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026